US Futures Trade Mixed As June Inflation Ticks Up: ASML, Morgan Stanley, Goldman Sachs, BofA Earnings In Focus U.S. stock futures swung between gains and losses on Wednesday after ending on a mixed note on Tuesday. Futures of major benchmark indices were mixed.
Tuesday's after hours session: top gainers and losers The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Small-Cap Gain Therapeutics Stock Falls On Phase 1 Data From Its Lead Asset For Parkinson's Disease Gain Therapeutics reported positive Phase 1 results for GT-02287, showing safety and tolerability across all age groups. The company plans a Parkinson's disease trial by Q4 2024.
GANX Stock Earnings: Gain Therapeutics Misses EPS for Q2 2024 GANX stock results show that Gain Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
7 Sorry Biotech Stocks Set to Make Investors Sad Biotech stocks can be extremely challenging because it takes a long time to bring a therapy to market. Here are some biotech stocks to sell.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday Pre-market stock movers are a hot topic on Friday and we're breaking down all of the latest news sending shares higher and lower!
Dear ARM Stock Fans, Mark Your Calendars for June 24 Arm stock is up on Friday and is preparing for a catalyst later this month when it replaces Sirius XM on the Nasdaq 100.
Why Is Gain Therapeutics (GANX) Stock Down 25% Today? Gain Therapeutics stock is down on Friday after the company priced an $11 million public offering for roughly 7 million shares of GANX.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday Pre-market stock movers are worth checking out on Friday as we dive into all of the biggest news moving shares this morning!
